Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06737016 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Tamsulosin for Children with Posterior Urethral Valve.

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 20, 2024 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Notable Trial status: Active, Not Recruiting to Recruiting Site details revisedv2 Show 1 more changeShow less
    • Site details revised
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To determine whether there is a role for Tamsulosin, A Selective Alpha-1 Adrenergic Blocker, as therapy in children with Posterior Urethral Valve post valve ablation , and whether there are side effects involved.
Trial Details
NCT Number NCT06737016
Lead Sponsor Mansoura University
Conditions Posterior Urethral Valve
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov